Internal Medicine, Gastroenterology · Glendale, CA
NPI
1841303849
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1560 E Chevy Chase Dr, Suite # 320
Glendale, CA, 91206
Phone (818) 241-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$567K
6,042 services
Medicare patients, 2024
1,901
Average age 74
Drug cost, 2024
$1.9M
5,478 prescriptions
Company payments, 2025
$14K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frederick A Boghossian was code 99233 (hospital e&m - subsequent), 1,013 times for 232 patients. In total Frederick A Boghossian billed 6,042 services in 22 codes, and Medicare paid $567K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,013 | 232 | $91.28 | $92K |
| 99213 Office E&M - Established | Office | 913 | 702 | $69.07 | $63K |
| 99232 Hospital E&M - Subsequent | Facility | 859 | 213 | $60.36 | $52K |
| 99203 Office E&M - New | Office | 835 | 835 | $81.76 | $68K |
| 43239 Upper GI Endoscopy | Facility | 570 | 555 | $68.70 | $39K |
| 99214 Office E&M - Established | Office | 494 | 472 | $100.65 | $50K |
| 99223 Hospital E&M - Initial | Facility | 375 | 329 | $133.15 | $50K |
| 45378 Lower GI Endoscopy - Other | Facility | 240 | 240 | $139.83 | $34K |
| 45385 Colonoscopy - Lesion Removal | Facility | 227 | 226 | $193.08 | $44K |
| 45384 Colonoscopy - Lesion Removal | Facility | 222 | 222 | $172.95 | $38K |
| 99222 Hospital E&M - Initial | Facility | 78 | 73 | $99.38 | $7,751 |
| 45380 Lower GI Endoscopy - Other | Facility | 62 | 62 | $153.28 | $9,504 |
| 99204 Office E&M - New | Office | 62 | 62 | $120.03 | $7,442 |
| 43246 Upper GI Endoscopy | Facility | 41 | 39 | $151.59 | $6,215 |
| 43255 Upper GI Endoscopy | Facility | 14 | 13 | $142.20 | $1,991 |
By year: 2022 $510K for 5,373 services; 2023 $539K for 5,696 services; 2024 $567K for 6,042 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frederick A Boghossian prescribed most often to Medicare patients was Linzess (Linaclotide), with 869 prescriptions and refills. In total Frederick A Boghossian wrote 5,478 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Linzess Linaclotide | 869 | 921 | 132 | $482K |
| Omeprazole Generic | 732 | 907 | 150 | $2,496 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 652 | 652 | 640 | $40K |
| Famotidine Generic | 455 | 507 | 151 | $1,481 |
| Hydrocortisone Generic | 289 | 297 | 55 | $2,856 |
| Procto-Med Hc Hydrocortisone | 253 | 263 | 49 | $3,423 |
| Creon Lipase/Protease/Amylase | 204 | 215 | 33 | $388K |
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 150 | 170 | 19 | $160K |
| Zenpep Lipase/Protease/Amylase | 138 | 149 | 26 | $374K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 131 | 131 | 129 | $1,927 |
| Dicyclomine Hcl Generic | 109 | 123 | 29 | $934 |
| Suprep Sodium, Potassium,mag Sulfates | 104 | 104 | 103 | $11K |
| Pantoprazole Sodium Generic | 101 | 129 | 17 | $537 |
| Mesalamine Generic | 100 | 121 | 14 | $48K |
| Clarithromycin Generic | 97 | 97 | 97 | $1,412 |
Brand drugs: 1,757 claims; generic drugs: 3,721 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frederick A Boghossian $14K ($14K in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.